The Global Fund to Fight AIDS, Tuberculosis and Malaria welcomed a landmark ruling by the High Court of Botswana to remove legal provisions that have led to discrimination and violence against lesbian, gay, bisexual and transgender people.
Takeda Pharmaceutical Company Limited today became the first private sector company to announce a financial commitment to the Global Fund’s Sixth Replenishment. The new pledge, consisting of JP ¥ 1 billion (approximately US$9 million) over five years, builds on Takeda's previous contribution to the Global Fund.
The Global Fund to Fight AIDS, Tuberculosis and Malaria warmly congratulated Algeria and Argentina for earning WHO certification as malaria-free and called on global partners to step up the fight to end the disease.
The Board of the Global Fund approved an allocation approach to maximize the impact of investments to end the epidemics and to build resilient and sustainable systems for health, stepping up efforts for the next three-year funding period.